These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 12001112)

  • 1. Increased mammography use and its impact on earlier breast cancer detection in Vermont, 1975-1999.
    Vacek PM; Geller BM; Weaver DL; Foster RS
    Cancer; 2002 Apr; 94(8):2160-8. PubMed ID: 12001112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer and earlier detection efforts. Realized and unrealized impact on stage.
    Farwell MF; Foster RS; Costanza MC
    Arch Surg; 1993 May; 128(5):510-3; discussion 513-4. PubMed ID: 8489384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do mammographic tumor features in breast cancer relate to breast density and invasiveness, tumor size, and axillary lymph node involvement?
    Sartor H; Borgquist S; Hartman L; Olsson Å; Jawdat F; Zackrisson S
    Acta Radiol; 2015 May; 56(5):536-44. PubMed ID: 24814360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old.
    Curpen BN; Sickles EA; Sollitto RA; Ominsky SH; Galvin HB; Frankel SD
    AJR Am J Roentgenol; 1995 May; 164(5):1099-103. PubMed ID: 7717212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Method of tumor detection influences disease-free survival of women with breast carcinoma.
    Senie RT; Lesser M; Kinne DW; Rosen PP
    Cancer; 1994 Mar; 73(6):1666-72. PubMed ID: 8156494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biennial versus annual mammography and the risk of late-stage breast cancer.
    White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
    J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Herrada J; Iyer RB; Atkinson EN; Sneige N; Buzdar AU; Hortobagyi GN
    Clin Cancer Res; 1997 Sep; 3(9):1565-9. PubMed ID: 9815844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapy.
    Barth RJ; Gibson GR; Carney PA; Mott LA; Becher RD; Poplack SP
    AJR Am J Roentgenol; 2005 Jan; 184(1):324-9. PubMed ID: 15615996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography.
    Weaver DL; Rosenberg RD; Barlow WE; Ichikawa L; Carney PA; Kerlikowske K; Buist DS; Geller BM; Key CR; Maygarden SJ; Ballard-Barbash R
    Cancer; 2006 Feb; 106(4):732-42. PubMed ID: 16411214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of women ages 40-49 years with breast carcinoma according to method of detection.
    McPherson CP; Swenson KK; Jolitz G; Murray CL
    Cancer; 1997 May; 79(10):1923-32. PubMed ID: 9149019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of delay to diagnosis on prognostic indicators of screen-detected breast carcinoma.
    Olivotto IA; Gomi A; Bancej C; Brisson J; Tonita J; Kan L; Mah Z; Harrison M; Shumak R
    Cancer; 2002 Apr; 94(8):2143-50. PubMed ID: 12001110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of mammography in 1096 consecutive patients with breast cancer, 1979-1993: equal value for patients younger and older than age 50 years.
    Cody HS
    Cancer; 1995 Nov; 76(9):1579-84. PubMed ID: 8635061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma.
    Tabar L; Tony Chen HH; Amy Yen MF; Tot T; Tung TH; Chen LS; Chiu YH; Duffy SW; Smith RA
    Cancer; 2004 Oct; 101(8):1745-59. PubMed ID: 15386334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overweight in relation to tumour size and axillary lymph node involvement in postmenopausal breast cancer patients-differences between women invited to vs. not invited to mammography in a randomized screening trial.
    Olsson A; Garne JP; Tengrup I; Zackrisson S; Manjer J
    Cancer Epidemiol; 2009 Jul; 33(1):9-15. PubMed ID: 19679041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging.
    Valente SA; Levine GM; Silverstein MJ; Rayhanabad JA; Weng-Grumley JG; Ji L; Holmes DR; Sposto R; Sener SF
    Ann Surg Oncol; 2012 Jun; 19(6):1825-30. PubMed ID: 22227922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubular carcinoma of the breast: mode of presentation, mammographic appearance, and frequency of nodal metastases.
    Elson BC; Helvie MA; Frank TS; Wilson TE; Adler DD
    AJR Am J Roentgenol; 1993 Dec; 161(6):1173-6. PubMed ID: 8249721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammographically detected breast cancers and the risk of axillary lymph node involvement: is it just the tumor size?
    Heimann R; Munsell M; McBride R
    Cancer J; 2002; 8(3):276-81. PubMed ID: 12074328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New era in breast cancer. Impact of screening on disease presentation.
    Cady B
    Surg Oncol Clin N Am; 1997 Apr; 6(2):195-202. PubMed ID: 9103207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.